These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 26458652)

  • 1. A rare case of ALK negative CD30+ primary cutaneous anaplastic large cell lymphoma in a young adult.
    Sridevi HB; Shanthala PR; Raghuveer CV; Prabhu AK; Akbar JK; Shivaprasad GS; Suresh PK; Navani S
    J Cancer Res Ther; 2015; 11(3):656. PubMed ID: 26458652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
    Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
    Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK-positive anaplastic large cell lymphoma with an unusual alveolar growth pattern.
    Yu G; Gao Z; Huang X
    Int J Clin Exp Pathol; 2014; 7(12):9086-9. PubMed ID: 25674293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.
    Cederleuf H; Bjerregård Pedersen M; Jerkeman M; Relander T; d'Amore F; Ellin F
    Br J Haematol; 2017 Sep; 178(5):739-746. PubMed ID: 28485010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary CNS involvement of ALK-negative anaplastic large cell lymphoma.
    Major A; Pan Z; Kamdar M
    Am J Hematol; 2017 Nov; 92(11):1267-1268. PubMed ID: 28370436
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
    Oregel KZ; Everett E; Zhang X; Nagaraj G
    Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Modality Management of Sinonasal Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma in a Young Adult-Report of a Rare Case.
    Biswas A; Devnani B; Agarwal S; Sharma MC; Sharma A
    J Adolesc Young Adult Oncol; 2019 Aug; 8(4):469-476. PubMed ID: 30994389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic large cell lymphoma, ALK-positive.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcomatoid Variant of Primary Cutaneous Anaplastic Large Cell Lymphoma.
    Natsuaki Y; Muto I; Kawamura M; Saruta H; Teye K; Ohshima K; Nakama T; Ohata C
    Am J Dermatopathol; 2019 Dec; 41(12):e164-e167. PubMed ID: 31268929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.
    Tsuyama N; Sakamoto K; Sakata S; Dobashi A; Takeuchi K
    J Clin Exp Hematop; 2017; 57(3):120-142. PubMed ID: 29279550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine needle aspiration cytology of ALK1(-), CD30+ anaplastic large cell lymphoma post renal transplantation: a case report and literature review.
    Balachandran I; Walker JW; Broman J
    Diagn Cytopathol; 2010 Mar; 38(3):213-6. PubMed ID: 19774614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated cutaneous involvement in a child with nodal anaplastic large cell lymphoma.
    Mendiratta V; Gandhi N; Rana S; Shukla S;
    Indian J Dermatol Venereol Leprol; 2016; 82(1):53-6. PubMed ID: 26728811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment for recurrence of primary cutaneous anaplastic large-cell lymphoma in elderly patient with etoposide, mitoxantrone, cyclophosphamide, vincristine, prednisolone and bleomycin (VNCOP-B) therapy.
    Isogai R; Fukao M; Kawada A
    J Dermatol; 2007 Aug; 34(8):556-60. PubMed ID: 17683387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary rare anaplastic large cell lymphoma, ALK positive in small intestine: case report and review of the literature.
    Cao Q; Liu F; Li S; Liu N; Li L; Li C; Peng T
    Diagn Pathol; 2016 Sep; 11(1):83. PubMed ID: 27612448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous involvement in systemic anaplastic large cell lymphoma.
    Kwok C; Salmo E
    J Dtsch Dermatol Ges; 2015 Jul; 13(7):693-5. PubMed ID: 26031654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary cutaneous CD30+ large T-Cell lymphoma with lymph node and cerebral metastases].
    Simal E; Hörndler C; Porta N; Baldellou R
    Actas Dermosifiliogr; 2010 Nov; 101(9):810-2. PubMed ID: 21034717
    [No Abstract]   [Full Text] [Related]  

  • 18. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
    Xing X; Feldman AL
    Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CD30-negative and ALK-positive anaplastic large cell lymphoma: report of a case].
    Li N; Ren D; Lü BB; Xie JL; Zheng XD; Gong LP; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):269-70. PubMed ID: 21616006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.